Skip to main content
. Author manuscript; available in PMC: 2022 Dec 15.
Published in final edited form as: Eur J Med Chem. 2021 Sep 4;226:113825. doi: 10.1016/j.ejmech.2021.113825

Fig. 4.

Fig. 4.

Schematic of an imaging-guided nanomedicine for targeted cancer chemoradiotherapy via increased DNA lesions formation and inhibited DNA damage response. Adapted with permission from Ref. [124].